Davids Lab Video Features

Meet the Man Behind the Pan-Mass Challenge in Massachusetts

Dr. Davids' PMC feature on the Today Show

Dr. Ryan discusses her approach to treating patients and how Dana-Farber's scientific advancements help develop new clinical therapies for lymphoma. 

At ASH22, Dr. Davids details a study in high-risk CLL that found a triplet regimen AVO was highly effective, with an 86% rate of undetectable minimal residual disease.

Watch Dr. Davids detail each type of treatment options available for patients with CLL in "An Overview of CLL Treatment Types" on the Patient Empowerment Network YouTube Channel.

Watch Dr. Christine Ryan speak with CLL Society’s Director of Scientific Affairs and Research, Robyn Brumble, RN, MSN in the "CLLS Research Program 2022 YIA Announcement Interview" on the Robyn Brumble YouTube Channel.

​Dr. Davids being interviewed on NESN RED SOX Final at Fenway Park for the 17th annual WEEI/NESN Jimmy Fund Radio-Telethon.

Check out Dr. Davids talking about his work treating patients with CLL, Hodgkin's, and non-Hodgkin's lymphoma at Dana-Farber Cancer Institute.